Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shujin Huoluo Wan is a Traditional Chinese Medicine (TCM) herbal formulation developed by Liaoning Chaohua Pharmaceutical Co., Ltd. It is presented as black-brown honeyed pills taken orally with warm water or ginger soup. The formulation contains multiple herbal ingredients including *Acanthopanax gracilistylus* (Wu Jia Pi), *Clematis chinensis* (Wei Ling Xian), *Notopterygium incisum* (Qiang Huo), *Siegesbeckia orientalis* (Xi Xian Cao), *Arisaema cum bile* (Dan Nan Xing), *Ligusticum chuanxiong* (Chuan Xiong), *Angelica pubescens* (Du Huo), *Cinnamomum cassia* (Gui Zhi), *Chaenomeles speciosa* (Mu Gua), *Angelica sinensis* (Dang Gui), *Achyranthes bidentata* (Niu Xi), and *Kadsura coccinea* (Di Feng Pi). The medicine's therapeutic functions are to expel wind and dampness, and to relax muscles and activate collaterals (Shu Jin Huo Luo). It is indicated for the treatment of arthralgia (joint pain), back pain, and knee pain. As a traditional herbal medicine, it does not have a single defined biological target or active ingredient in the Western pharmaceutical sense, but rather works through the synergistic effects of its multiple herbal components according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shujin Huoluo Wan.